Adcock Ingram is a leading South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange.
The company's mission is to provide quality products that improve the health and lives of people in the markets they serve.... [more info]
Viv Govender of Rand Swiss on the market's reaction to the budget. AECI CEO Mark Dytor unpacks their results as geographic diversification pays off and Adcock Ingram's CEO, Andy Hall, talks results showing healthcare continues to struggle under the pandemic.
Mia Kruger of Kruger International on Stadio's results and the new PSG 3.0. Henry Laas, Murray and Roberts CEO, on the pandemic pushing the company into a loss. Linebooker CEO, Naude Rademan, talks ARC taking a stake in the business.
CEO Andy Hall explains issues related to pricing flexibility, wages, import costs, efficiency, being debt-free, and the outlook for unregulated acquisitions.
SEARCH ARTICLES BY COMPANY
Enter company name or share code:
SEARCH COMPANIES
Enter company name or share code:
Moneyweb requires cookies to function properly. By continuing to use our website, we assume you are okay with it. For more information on how we use cookies and how to disable it, please read our
Terms of use.
Africa Wealth Report 2021 estimates around 4 200 millionaires left SA over the past decade, but the depreciating rand and Covid-19 fall-out are also to blame.